Search alternatives:
nn decrease » mean decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
_ nn » _ cnn (Expand Search), _ ann (Expand Search), _ knn (Expand Search)
nn decrease » mean decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
_ nn » _ cnn (Expand Search), _ ann (Expand Search), _ knn (Expand Search)
-
1
-
2
-
3
Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses
Published 2025Subjects: -
4
-
5
Temporal profiles of the key BO-NN features.
Published 2020“…Right plot show the gradual decrease in the TM tuning for the features highlighted in <b>c</b> as well as the gradual increase in the temporal response profile (i.e. optimal shifts for the prediction of the key BO-NN features using Praat features shown in <b>a</b>). …”
-
6
-
7
The Dose–Response Decrease in Heart Rate Variability: Any Association with the Metabolites of Polycyclic Aromatic Hydrocarbons in Coke Oven Workers?
Published 2012“…After adjustment for potential confounders, elevation per interquartile range (IQR) (1.81 µg/mmol creatinine) of urinary 2-hydroxynaphthalene was associated with a 5.46% (95% CI, 2.50–8.32) decrease in standard deviation of NN intervals (SDNN). …”
-
8
Decreased oscillatory flow decreases <i>klf2a</i> expression.
Published 2009“…(G) <i>klf2a</i> expression decreases after 15-h lidocaine treatment (90%, <i>n</i> = 67). …”
-
9
-
10
-
11
-
12
-
13
-
14
-
15
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
-
16
-
17
-
18
-
19
-
20